Phase 2 N=20 Trial of Topical Cidofovir for the Prevention of Hair Growth
Prevention of Hair Growth
Primary: Physician's Global Assessment (PGA) of Hair Density — 1; 0; 1 participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=87 The Efficiency of the Hair2Go Device: A Prospective, Open, Label Study With Before-After Design
Hair Removal
Primary: Hair Clearance 1 Month After Last Treatment — 56.83; 54.08 %baseline hair count
N/A N=44 A Novel Approach to Treating Androgenetic Alopecia in Females With Low Level Laser Therapy
Androgenetic Alopecia
Primary: Percentage Increase in Terminal Hair Counts From Pre-Treatment, Baseline for Active Test Subjects Over the Placebo Test Subjects. — 12.48; 63.67 percent change — p=<0.001
N/A N=37 Safety for Frequent Use Conditions of Hair Removal Device
Hair Removal
Primary: Percentage of Participants With Device Related Anticipated Skin Effects, Serious Adverse Events, or Adverse Events. — 0; 0; 0 percentage of particpants
N/A N=10 Ultrasound Device for Hair Removal
Hair Removal
Primary: Reduction in Hair Count in the Treated Area — 13.1; 10.7; 18.7 percentage of hair reduction
N/A N=11 Pilot Study of a Novel IPL for Removal of Unwanted Fine Body Hair
Hypertrichosis
Primary: Comparison of Percent Hair Reduction Between Treatment Arm and Non-treated Control Arm at 12 Weeks Post Final Treatment — 41; 27 percent reduction
N/A N=72 Treatment of Androgenetic Alopecia in Females, 9 Beam
Androgenetic Alopecia · Hair Loss · Female Pattern Baldness
Primary: Changes in Terminal Hair Count Week 16 and 26 Weeks Over Baseline — 1.3; 14.8; 2.8; 20.2 hairs per cm^2
N/A N=49 Treatment of Androgenetic Alopecia in Males
Androgenetic Alopecia · Hair Loss · Male Pattern Baldness
Primary: Changes in Terminal Hair Count at 16 and 26 Weeks Over Baseline — 17.7; 2.8; 18.4; 1.6 change in terminal hair count
Phase 3 N=20 Comparison of Efficacy, Safety and Tolerability of Two Different 810 nm Diode Lasers for Hair Reduction
Hypertrichosis
Primary: Change in Hair Growth — 57.6; 52.1; 39.3; 29.9 % hair reduction — p=0.2879
N/A N=35 Hair Count Reduction Verification Study With the LightSheer Duet HS Handpiece
Hair Removal
Primary: Hair Count — 54 percentage of hair clearance — p=<0.001
N/A N=63 Treatment of Androgenetic Alopecia in Females, 12 Beam
Androgenetic Alopecia · Hair Loss · Female Pattern Baldness
Primary: Change in Hair Count at 16 and 26 Weeks Over Baseline — -0.8; 12.5; 3.0; 20.6 hairs per cm^2
N/A N=17 Clinical Evaluation of Silk'n Glide for Face
Hirsutism
Primary: 1. Comparison of Hair Counts Before Treatments to 4 and 12 Weeks Follow up Visits. — 83.3; 78.1 percentage of hair reduction
N/A N=13 Pilot Study of Laser Hair Depilation for Pilonidal Disease
Pilonidal Disease
Primary: Tolerability of Laser Treatment — 2 score on a scale
N/A N=46 Hair Care Product Use Among Women Of Color
Breast Cancer · Pregnancy Related · Exposure During Pregnancy
Primary: Change in Internal Dose of Urinary Phthalate Metabolites — 1.9 percent change of sumLMW
N/A N=20 Efficacy Study of a Cosmetic Lotion in the Treatment of Androgenetic Alopecia in Males and Females
Androgenetic Alopecia
Primary: Change of the Amount of Hair Loss in a Pull Test — 2.75 Fallen hair
N/A N=9 Hair Loss Prevention Study for Pancreatic Cancer
Alopecia
Primary: Hair Preservation — 2; 3 Participants
N/A N=29 Pre-Shave Gel and Brush in Pseudofolliculitis Barbae
Pseudofolliculitis Barbae
Primary: Patient Global Severity Assessment- Mechanics of Shaving — 12.9; 12.4; 8.5; 9.7 score on a scale
N/A N=160 Modulated Light Therapy in Participants With Pattern Hair Loss
Androgenetic Alopecia
Primary: Mean Change in Terminal Hair Count From Baseline to 16 Weeks — -15.53; 14.26; 18.94; 5.22 Change in total hair counts
N/A N=12 Penguin Cold Caps in the Prevention of Hair Loss in Breast Cancer Patients
Breast Cancer
Primary: Efficacy of PenguinTM Cold-caps for Prevention or Reduction of CIA — 4; 3; 3 Participants
N/A N=79 Treatment of Androgenic Alopecia in Males
Androgenetic Alopecia · Hair Loss · Male Pattern Baldness
Primary: Changes in Terminal Hair Count at 16 and 26 Weeks Compared to Baseline in Men Diagnosed With Androgenetic Alopecia — 23.5; 20.4; 4.4; 25.7 hairs per cm^2
N/A N=11 Treatment of Acne Keloidalis Nuchae (Razor Bumps Behind the Neck) Using UV Light Therapy
Acne Keloidalis Nuchae
Primary: Percentage Change in Total AKN Lesions From Baseline to Week 16. — 49 percentage of lesion count reduction
Phase 2 N=9 Topical Bimatoprost Effect on Androgen Dependent Hair Follicles
Male Pattern Hair Loss · Androgenetic Alopecia
Primary: Percent Change in Target Area Total Hair Count — -2.6; 27.4; 4.9; -5.8 percentage change in total hair count
Phase 3 N=24 Evaluating the Topical Herbal Solution on the Treatment of Male Pattern Hair Loss and Comparison With Minoxidil 5%
Androgenetic Alopecia
Primary: Change in Hair Diameter — 57.42; 51.58; 60.92; 51.17 micrometer
N/A N=61 Minoxidil 2% Solution and Botanical Hair Regimen in Women With Thinning Hair and Female Pattern Hair Loss/Androgenic Alopecia
Female Pattern Hair Loss, Androgenic Alopecia
Primary: Change From Baseline in Investigator's Rating of Global Photographs at Week 12 — 4.9; 4.9; 4.8; 5.0 Score on a scale
Phase 2 N=120 To Investigate Efficacy of FOL-005 on Hair Growth on Scalp Skin
Androgenic Alopecia
Primary: Scalp Hair Density — 1.46; 2.58; -4.10; 6.68 Change from baseline (No. of hairs/cm2)
Phase 3 N=322 Clinical Trial in Females With Female Pattern Hair Loss
Alopecia
Primary: Target Area Hair Count (TAHC) — 167.3; 169.7; 192.8; 194.4 hairs per centimeter squared — p=0.9170
Phase 1 N=30 A Study of Effect of Deodorant and Axillary Hair on Testosterone Absorption in Healthy Participants
Healthy Participants
Primary: Pharmacokinetics: Area Under the Concentration Curve (AUC) of Testosterone — 2120; 2400; 2970; 2880 nanograms* hours per deciliter (ng*h/dL)
N/A N=63 Minoxidil 5% / Botanical Hair Regimen in Men With Thinning Hair and Male Pattern Hair Loss/Androgenic Alopecia
Male Pattern of Hair Loss, Androgenic Alopecia
Primary: Change From Baseline in Investigator's Rating of Standardized Global Photographs at Week 12 — 5.0; 5.1; 5.1; 5.1 Score on a scale
N/A N=8 Follicular Revival in Androgenic Alopecia: Evaluating Use of Micro-needling
Androgenic Alopecia
Primary: Total Area Hair Count — 126.8 hairs per cm^2
Phase 2 N=20 Platelet Rich Plasma Versus Minoxidil Foam for Treatment of Androgenic Alopecia in Women
Alopecia
Primary: Change in Hair Count — 7.7; 22.7 percent change — p=.009